ARAVIVE, INC.

Profile

Company Names

ARAVIVE, INC.
VERSARTIS, INC.

Addresses

3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX 77098

275 SHORELINE DRIVE, SUITE 450, REDWOOD CITY, CA 94065

500 ELLIS STREET, MOUNTAIN VIEW, CA 94043

Phone Numbers

936-355-1910
6509638588

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$151,479,849.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2022-10-27 
$41,560,000.00 
$41,560,000.00 
$0.00 
Equity 
6
2014-02-14 
$54,999,991.00 
$54,999,991.00 
$0.00 
Equity 
5
2014-02-04 
$10,000,000.00 
$10,000,000.00 
$0.00 
Equity 
4
2013-10-01 
$9,999,999.00 
$9,999,999.00 
$0.00 
Equity 
3
2013-07-08 
$12,499,999.00 
$12,499,999.00 
$0.00 
Equity 
2
2013-01-07 
$7,999,999.00 
$20,499,999.00 
$12,500,000.00 
Equity 
1
2011-02-14 
$14,419,861.00 
$21,107,360.00 
$6,687,499.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SRINIVAS 
 
AKKARAJU 
DIRECTOR
SEATTLE GENETICS INC /WA   |  PRESIDIO PHARMACEUTICALS, INC.   |  VERSARTIS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  SYROS PHARMACEUTICALS, INC.   |  SAMSARA BIOCAPITAL, L.P.   |  565 SPV I, L.P.   |  TENTARIX BIOTHERAPEUTICS, LP   |  CHINOOK THERAPEUTICS U.S., INC.   |  MINERALYS THERAPEUTICS, INC.   |  ORSOBIO, INC.   |  VTV THERAPEUTICS INC.   |  ALUMIS INC.   |  SAMSARA OPPORTUNITY FUND, L.P.
JOSHUA 
 
BRUMM 
EXECUTIVE OFFICER
VERSARTIS, INC.   |  DYNE THERAPEUTICS, INC.
JEFFREY 
 
CLELAND 
EXECUTIVE OFFICER, DIRECTOR
VERSARTIS, INC.   |  GRAYBUG LLC   |  GRAYBUG, INC.   |  ASHVATTHA THERAPEUTICS, LLC   |  ORPHERIS, INC.   |  GRAYBUG VISION, INC.   |  ASHVATTHA THERAPEUTICS, INC.   |  ELIXIRGEN THERAPEUTICS, INC.
FRANCESCO 
 
DE RUBERTIS 
DIRECTOR
NORMOXYS INC   |  NORMOXYS, INC.   |  VERSARTIS, INC.   |  MINERVA NEUROSCIENCES, INC.   |  MEDICXI GROWTH I LP   |  MEDICXI III LP   |  MEDICXI SECONDARY I LP   |  RIVUS PHARMACEUTICALS, INC.
LEONARD 
SCOTT 
DOVE 
EXECUTIVE OFFICER
ARAVIVE, INC.
MICHAEL 
 
DYBBS 
DIRECTOR
VERSARTIS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  SAMSARA BIOCAPITAL, L.P.   |  SUTRO BIOPHARMA INC   |  NKARTA, INC.   |  565 SPV I, L.P.   |  LEVO THERAPEUTICS, INC.   |  DELFI DIAGNOSTICS, INC.   |  ABCURO, INC.   |  SAMSARA OPPORTUNITY FUND, L.P.
FREDRIC 
N. 
ESHELMAN 
EXECUTIVE OFFICER, DIRECTOR
INCYCLIX BIO, LLC   |  ARAVIVE, INC.
ROBERT 
B. 
GELLER 
EXECUTIVE OFFICER
ARAVIVE, INC.
AMATO 
 
GIACCIA 
DIRECTOR
ARAVIVE BIOLOGICS, INC.   |  ARAVIVE, INC.
PETER 
T.C. 
HO 
DIRECTOR
ARAVIVE, INC.
JOHN 
A. 
HOHNECKER 
DIRECTOR
ARAVIVE, INC.
RUDY 
 
HOWARD 
EXECUTIVE OFFICER
AMBER ROAD, INC.   |  METABOLON, INC   |  VTV THERAPEUTICS INC.   |  ARAVIVE, INC.
EDMON 
 
JENNINGS 
DIRECTOR
VERSARTIS, INC.
KEVIN 
 
JOHNSON 
DIRECTOR
FIRESCOPE INC   |  AUREON LABORATORIES INC   |  RADIUS INVESTMENT GROUP, LLC   |  PRECISION THERAPEUTICS INC   |  AUREON BIOSCIENCES, INC.   |  VERSARTIS, INC.   |  ACUTUS MEDICAL, INC.   |  JUNIPER NETWORKS INC   |  UNITED BIOLOGICS HOLDINGS, LLC   |  WICHITA AIRPORT HOSPITALITY, LLC   |  INVESCO U.S. INCOME REIT, LLC   |  IREF IV REIT, LLC   |  ICRE REIT HOLDINGS   |  FACTORY REIT LLC   |  CLEANCAPITAL LLC   |  SPECTRUM MANAGEMENT, LLC   |  CLEANCAPITAL PORTFOLIO 1, LLC   |  SSA SOLAR OF CA 2, LLC   |  SSA SOLAR OF OR, LLC   |  SSA SOLAR OF CA, LLC   |  POSITIVE ENERGY PENNSYLVANIA 1, LLC   |  SSA SOLAR OF NJ LLC   |  NEUSE RIVER SOLAR FARM, LLC   |  POSITIVE ENERGY COLORADO 10, LLC   |  SSA SOLAR OF DE, LLC   |  SSA SOLAR OF CO, LLC   |  SSA SOLAR OF CO 1, LLC   |  POSITIVE ENERGY COLORADO 6, LLC   |  POSITIVE ENERGY COLORADO 1, LLC   |  CLEANCAPITAL HOLDCO 1, LLC   |  MEDICXI GROWTH I LP   |  ATSCALE, INC.   |  SYDNEXIS, INC.   |  QUEST GROUP TRUST VIII   |  QUEST GROUP TRUST VII   |  QUEST GROUP TRUST V   |  QUEST GROUP TRUST IV   |  QUEST GROUP TRUST III   |  QUEST GROUP TRUST II   |  QUEST GROUP TRUST I   |  QUEST GROUP TRUST VI   |  MEDICXI III LP   |  MERCHANTWISE SOLUTIONS, LLC   |  MEDICXI SECONDARY I LP   |  TWIN HEALTH, INC.
SIGURD 
C. 
KIRK 
DIRECTOR
ARAVIVE, INC.
SHAHZAD 
 
MALIK 
DIRECTOR
CONATUS PHARMACEUTICALS INC   |  PATHWORK DIAGNOSTICS INC   |  VERSARTIS, INC.   |  ACUTUS MEDICAL, INC.   |  IDUN PHARMACEUTICALS INC   |  ADVENT LIFE SCIENCES FUND II LP   |  AGENUS INC   |  NALU MEDICAL, INC.   |  AXONICS MODULATION TECHNOLOGIES, INC.   |  ITERUM THERAPEUTICS LTD   |  ADVENT LIFE SCIENCES FUND III LP   |  ITERUM THERAPEUTICS BERMUDA LTD   |  ITERUM THERAPEUTICS PLC   |  ITERUM THERAPEUTICS US LTD   |  ITERUM THERAPEUTICS US HOLDING LTD   |  ITERUM THERAPEUTICS INTERNATIONAL LTD   |  ADVENT-HARRINGTON IMPACT FUND LP   |  MOXIMED, INC   |  ADVENT LIFE SCIENCES GROWTH FUND LP
GAIL 
 
MCINTYRE 
EXECUTIVE OFFICER, DIRECTOR
TAXIS PHARMACEUTICALS INC.   |  ARAVIVE, INC.
MICHAEL 
W. 
ROGERS 
DIRECTOR
SAJAN INC   |  BG MEDICINE, INC.   |  CORONADO BIOSCIENCES INC   |  ARAVIVE, INC.
VOLKER 
 
SCHELLENBERGER 
DIRECTOR
VERSARTIS, INC.   |  AMUNIX PHARMACEUTICALS, INC.
JAY 
 
SHEPARD 
DIRECTOR
NEXTWAVE PHARMACEUTICALS INC   |  BULLET BIOTECHNOLOGY, INC.   |  VERSARTIS, INC.   |  NEURORECOVERY TECHNOLOGIES, INC.   |  INOVIO PHARMACEUTICALS, INC.   |  CESSATION THERAPEUTICS, INC.
WILLEM 
 
STEMMER 
DIRECTOR
VERSARTIS, INC.
ANTHONY 
 
SUN 
DIRECTOR
CENERX BIOPHARMA INC   |  NEOCONIX INC   |  BRIDGE PHARMACEUTICALS, INC.   |  LAVANTE INC   |  CANESTA INC   |  VERSARTIS, INC.   |  PACKET PHOTONICS, INC.   |  IMMUSOFT CORP   |  EYENOVIA, INC.   |  ALLOY THERAPEUTICS, INC.
PAUL 
 
WESTBERG 
EXECUTIVE OFFICER
VERSARTIS, INC.
ERIC 
 
ZHANG 
DIRECTOR
CHINA PHARMAHUB CORP.   |  GENERAL ATLANTIC INVESTMENT PARTNERS 2021, L.P.   |  GENERAL ATLANTIC BNZ COMPANION FUND, L.P.   |  GENERAL ATLANTIC BNZ COMPANION FUND (LUX), SCSP   |  PEACHY CORP.   |  ARAVIVE, INC.   |  GENERAL ATLANTIC BNZ ONSHORE CO-INVEST, L.P.   |  GENERAL ATLANTIC BNZ OFFSHORE CO-INVEST (BERMUDA), L.P.   |  GENERAL ATLANTIC BNZ FEEDER FUND (BERMUDA), L.P.   |  IRON PARK OPPORTUNISTIC CAPITAL FUND (OFFSHORE), LP   |  IRON PARK OPPORTUNISTIC CAPITAL FUND (ONSHORE), LP   |  GENERAL ATLANTIC INVESTMENT PARTNERS SCSP SICAV-RAIF   |  GENERAL ATLANTIC INVESTMENT PARTNERS 2023, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-10-27 
2014-02-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-14 
2014-02-19
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-04 
2013-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-01 
2013-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-08 
2013-01-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-07 
2013-01-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-01-07 
2011-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
MTS SECURITIES, LLC
104059